Perbedaan Jantra Grupo Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Jantra Grupo Indonesia Tbk. diperdagangkan di Rp98 (kapitalisasi pasar 201,35 M, volume 24 jam 38,62 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jantra Grupo Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| KAQI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 201,35 M | 104,4 M |
Volume | 38,62 jt | — |
Lot | 386,24 rb | — |
Perputaran | 3,75 M | — |
Harga Rata-rata | 97,02 | — |
Nilai Transaksi | 3,75 M | — |
Harga Ekuilibrium Indikatif | 98 | — |
Volume Ekuilibrium Indikatif | 16,32 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Jantra Grupo Indonesia Tbk (Company) was established on 26 September 2017 based on a Deed Notary No. 102 was made by Suhardi Hadi Santoso, S.H., Notary in Jakarta.
Selengkapnya di halaman KAQI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →